{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:35:07Z","timestamp":1782894907101,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-050867"],"award-info":[{"award-number":["INV-050867"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"crossref","award":["D43TW010060"],"award-info":[{"award-number":["D43TW010060"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institute of Child Health and Human Development","award":["1P01HD112215"],"award-info":[{"award-number":["1P01HD112215"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pregnant and breastfeeding women are at elevated risk of HIV acquisition. The World Health Organization (WHO) recommends use of oral TDF\/FTC and long-acting injectables cabotegravir (CAB-LA) and lenacapavir (LEN) for HIV pre-exposure prophylaxis (PrEP) in pregnancy. However, safety data for emerging regimens remain limited due to the exclusion of pregnant women from early clinical trials and insufficient routine, program-embedded surveillance, especially in resource-constrained settings. In March 2024, as Malawi introduced CAB-LA, the PrEP Pregnancy Registry was established to generate real-world safety data on PrEP exposure during pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The PrEP Pregnancy Registry provides prospective safety surveillance of pregnant women on PrEP within routine service delivery across Malawi. Guided by the WHO collaborative framework for antiretroviral safety in pregnancy, the Registry was established through a phased process involving the Malawi Ministry of Health, research and implementing partners. Initially implemented at five CAB-LA early-access facilities, it was refined with provider feedback and expanded to 30 additional facilities. The registry utilizes ScanForm, an AI-powered tool that uses optical character recognition technology to digitize and analyze handwritten data. Birth outcomes are measured using WHO\u2019s harmonized pharmacovigilance indicators for maternal and infant birth outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The Registry provides a scalable model for real-world pharmacovigilance of PrEP use in pregnancy. The use of ScanForm technology maximizes data quality and ensures integration with existing systems. Resulting evidence will fill critical gaps in PrEP safety data during pregnancy and inform national and global policies for integrating CAB-LA and emerging PrEP regimens into routine maternal health care settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration Numbers<\/jats:title>\n                    <jats:p>\n                      The Pregnancy, Infant and Maternal Health Outcomes (PrIMO) sub-study within the Preventing Infant Infection with Implementation Science in Malawi (PRI\n                      <jats:sup>3<\/jats:sup>\n                      SM) was registered in ClinicalTrials.gov on 05th December 2023 with trial registration number NCT06158126, and the Path to Scale study was registered on 29th March 2024 with trial registration number NCT06319105.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-026-09190-2","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:23:47Z","timestamp":1778199827000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Developing a surveillance system for HIV pre-exposure prophylaxis (PrEP) use in pregnancy in Malawi"],"prefix":"10.1186","volume":"26","author":[{"given":"Funny","family":"Kamanga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine A.","family":"Squibb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Watipa","family":"Nyangulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiehua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chatonda","family":"Ngwira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Drabko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiktor","family":"Garbarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Pomykala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Bilicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charity","family":"Nakanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladwell","family":"Masiye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lameck","family":"Chinula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tisungane","family":"Mvalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maganizo B.","family":"Chagomerana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitch M.","family":"Matoga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiza","family":"Kumwenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawonga","family":"Mkochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Matola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nomthata","family":"Mkochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Thonyiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose K.","family":"Nyirenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linley","family":"Chewere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Washington","family":"Ozituosauka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Jahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Nkhonjera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Odek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Hoege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheree","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felluna","family":"Chauwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufia","family":"Dadabhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Phiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Rutstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Herce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irving","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Allinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles B.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina C.","family":"Hosseinipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friday","family":"Saidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"9190_CR1","unstructured":"Joint United Nations Programme on HIV\/AIDS. AIDS, crisis and the power to transform: UNAIDS Global AIDS Update 2025. Geneva: UNAIDS. 2025. Available from: https:\/\/www.unaids.org\/en\/UNAIDS-global-AIDS-update-2025. Cited 10 Sep 2025."},{"issue":"1","key":"9190_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/infdis\/jiy113","volume":"218","author":"KA Thomson","year":"2018","unstructured":"Thomson KA, Hughes J, Baeten JM, John-Stewart G, Celum C, Cohen CR, et al. Increased Risk of HIV Acquisition among Women Throughout Pregnancy and during the Postpartum Period: A Prospective Per-Coital-Act Analysis among Women with HIV-Infected Partners. J Infect Dis. 2018;218(1):16\u201325. https:\/\/doi.org\/10.1093\/infdis\/jiy113 . PubMed PMID: 29514254.","journal-title":"J Infect Dis"},{"key":"9190_CR3","doi-asserted-by":"publisher","unstructured":"Machekano R, Tiam A, Kassaye S, Tukei V, Gill M, Mohai F, et al. HIV incidence among pregnant and postpartum women in a high prevalence setting. PLoS ONE. 2018;13(12). https:\/\/doi.org\/10.1371\/journal.pone.0209782 . PubMed PMID: 30592749.","DOI":"10.1371\/journal.pone.0209782"},{"issue":"5","key":"9190_CR4","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/QAD.0000000000002487","volume":"34","author":"LA Graybill","year":"2020","unstructured":"Graybill LA, Kasaro M, Freeborn K, Walker JS, Poole C, Powers KA, et al. Incident HIV among pregnant and breast-feeding women in sub-Saharan Africa: A systematic review and meta-analysis. AIDS. 2020;34(5):761\u201376. 10. 1097\/QAD.0000000000002487 PubMed PMID: 32167990.","journal-title":"AIDS"},{"key":"9190_CR5","doi-asserted-by":"publisher","unstructured":"Davey JD, Malaba TR. Oral PrEP safety in pregnancy with longitudinal follow-up of children for 36 months. 2025 Mar. Report. Available from: https:\/\/europepmc.org\/article\/med\/40021292https:\/\/doi.org\/10.1016\/s2214-109x(24)00531-x PubMed PMID: 40021292. Cited 11 Sep 2025.","DOI":"10.1016\/s2214-109x"},{"key":"9190_CR6","unstructured":"World Health Organization. Guidelines on long-acting injectable cabotegravir for HIV prevention. Geneva. 2022. Report. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240054097. Cited 10 Sep 2025."},{"key":"9190_CR7","doi-asserted-by":"publisher","DOI":"10.2471\/B09483","volume-title":"Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis","author":"World Health Organization","year":"2025","unstructured":"World Health Organization. Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Geneva: Report; 2025."},{"key":"9190_CR8","unstructured":"World Health Organization. WHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection: provider module for oral and long-acting PrEP. Geneva. 2024. Report. Available from: https:\/\/www.who.int\/tools\/prep-implementation-tool. Cited 10 Sep 2025."},{"key":"9190_CR9","doi-asserted-by":"publisher","unstructured":"Joseph Davey DL, Pintye J, Baeten JM, Aldrovandi G, Baggaley R, Bekker LG et al. Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading?. 2020. https:\/\/doi.org\/10.1002\/jia2.25426\/full","DOI":"10.1002\/jia2.25426\/full"},{"key":"9190_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/frph.2023.1221101","author":"L Fairlie","year":"2023","unstructured":"Fairlie L, Lavies D, Kalk E, Mhlongo O, Patel F, Technau KG, et al. Safety surveillance for PrEP in pregnant and breastfeeding women. Front Reproductive Health Front Media SA. 2023. https:\/\/doi.org\/10.3389\/frph.2023.1221101.","journal-title":"Front Reproductive Health Front Media SA"},{"key":"9190_CR11","doi-asserted-by":"publisher","unstructured":"Mofenson LM. Tenofovir Pre-exposure Prophylaxis for Pregnant and Breastfeeding Women at Risk of HIV Infection: The Time is Now. PLoS Med. 2016;13(9). https:\/\/doi.org\/10.1371\/journal.pmed.1002133.","DOI":"10.1371\/journal.pmed.1002133"},{"key":"9190_CR12","unstructured":"Nachega JB, Uthman OA, Mofenson LM, Anderson JR, Kanters S, Renaud F et al. Safety of Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis. J Acquir Immune Defic Syndr. 2017. Report. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5553236\/. Cited 10 Sep 2025."},{"issue":"7","key":"9190_CR13","doi-asserted-by":"publisher","first-page":"E1893","DOI":"10.1093\/cid\/ciaa","volume":"73","author":"L Stranix-Chibanda","year":"2021","unstructured":"Stranix-Chibanda L, Anderson PL, Kacanek D, Hosek S, Huang S, Nematadzira TG, et al. Tenofovir Diphosphate Concentrations in Dried Blood Spots from Pregnant and Postpartum Adolescent and Young Women Receiving Daily Observed Pre-exposure Prophylaxis in Sub-Saharan Africa. Clin Infect Dis. 2021;73(7):E1893\u2013900. https:\/\/doi.org\/10.1093\/cid\/ciaa. 1872 PubMed PMID: 33341883.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"9190_CR14","doi-asserted-by":"publisher","first-page":"e214","DOI":"10.1016\/S2352-3018","volume":"9","author":"DL Joseph Davey","year":"2022","unstructured":"Joseph Davey DL, Bekker LG, Bukusi EA, Chi BH, Delany-Moretlwe S, Goga A, et al. Where are the pregnant and breastfeeding women in new pre-exposure prophylaxis trials? The imperative to overcome the evidence gap. Lancet HIV. 2022;9(3):e214\u201322. https:\/\/doi.org\/10.1016\/S2352-3018. (21)00280-0 PubMed PMID: 35090604.","journal-title":"Lancet HIV"},{"issue":"4","key":"9190_CR15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/QAD.0000000000003803","volume":"38","author":"LF Johnson","year":"2024","unstructured":"Johnson LF, Myer L, Jamieson L, Meyer-Rath G, Delany-Moretlwe S, Joseph Davey D. The potential benefits of long-acting injectable cabotegravir in pregnant and breastfeeding women and their infants. AIDS. 2024;38(4):589\u201394. 10. 1097\/QAD.0000000000003803 PubMed PMID: 38016171.","journal-title":"AIDS"},{"key":"9190_CR16","unstructured":"World Health Organization. Landscape Analysis of Pregnancy Exposure Registries in Low- and Middle-Income Countries. Geneva: World Health Organization. 2023. Available from: https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/igo\/. Cited 11 Sep 2025."},{"key":"9190_CR17","doi-asserted-by":"publisher","unstructured":"Hodge D, Back DJ, Gibbons S, Khoo SH, Marzolini C. Pharmacokinetics and Drug\u2013Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine. Clin Pharmacokinet Adis. 2021;835\u201353. https:\/\/doi.org\/10.1007\/s40262-021-01005-1 . PubMed PMID: 33830459.","DOI":"10.1007\/s40262-021-01005-1"},{"issue":"3","key":"9190_CR18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.18773\/austprescr.2022.026","volume":"45","author":"Y Hughes","year":"2022","unstructured":"Hughes Y, Tomlins L, Usherwood T. Prescribing for patients taking antiretroviral therapy. Aust Prescr. 2022;45(3):80\u20137. https:\/\/doi.org\/10.18773\/austprescr.2022.026.","journal-title":"Aust Prescr"},{"key":"9190_CR19","doi-asserted-by":"publisher","unstructured":"Abushweimeh R, Knudson S, Chaabane S, Pal SN, Skidmore B, Stergachis A, et al. Pregnancy exposure registries for drugs and vaccines in low-income and middle-income countries: Scoping review protocol. BMJ Open. 2023;13(5). https:\/\/doi.org\/10.1136\/bmjopen-2022-070543 . PubMed PMID: 37156596.","DOI":"10.1136\/bmjopen-2022-070543"},{"key":"9190_CR20","doi-asserted-by":"publisher","unstructured":"Willis CD, McNeil JJ, Cameron PA, Phillips LE. Monitoring drug safety with registries: Useful components of postmarketing pharmacovigilance systems. Journal of Clinical Epidemiology. Elsevier USA; 2012. pp. 121\u20135. https:\/\/doi.org\/10.1016\/j.jclinepi.2011.06.017.","DOI":"10.1016\/j.jclinepi.2011.06.017"},{"key":"9190_CR21","doi-asserted-by":"publisher","unstructured":"Gill MM, Khumalo PN, Hoffman HJ, Chouraya C, Kunene M, Dlamini F, et al. Birth Defects and Adverse Pregnancy Outcomes in Hospital-based Birth Surveillance in Eswatini. Pediatr Infect Disease J. 2025 May;1. https:\/\/doi.org\/10.1097\/INF.0000000000004745.","DOI":"10.1097\/INF.0000000000004745"},{"key":"9190_CR22","doi-asserted-by":"publisher","unstructured":"Shafi J, Virk MK, Kalk E, Carlucci JG, Chepkemoi A, Bernard C, et al. Pharmacovigilance in Pregnancy Studies, Exposures and Outcomes Ascertainment, and Findings from Low- and Middle-Income Countries: A Scoping Review. Drug Safety. Adis; 2024. pp. 957\u201390. https:\/\/doi.org\/10.1007\/s40264-024-01445-1 . PubMed PMID: 38907172.","DOI":"10.1007\/s40264-024-01445-1"},{"key":"9190_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/frph.2021.672446","author":"EM Lokken","year":"2021","unstructured":"Lokken EM, Mathur A, Bunge KE, Fairlie L, Makanani B, Beigi R, et al. Pooled Prevalence of Adverse Pregnancy and Neonatal Outcomes in Malawi, South Africa, Uganda, and Zimbabwe: Results From a Systematic Review and Meta-Analyses to Inform Trials of Novel HIV Prevention Interventions During Pregnancy. Front Reproductive Health Front Media SA. 2021. https:\/\/doi.org\/10.3389\/frph.2021.672446.","journal-title":"Front Reproductive Health Front Media SA"},{"issue":"1","key":"9190_CR24","doi-asserted-by":"publisher","first-page":"E78","DOI":"10.1055\/s-0040-1708491","volume":"10","author":"KM Antony","year":"2020","unstructured":"Antony KM, Kazembe PN, Pace RM, Levison J, Phiri H, Chiudzu G, et al. Population-Based Estimation of the Preterm Birth Rate in Lilongwe, Malawi: Making Every Birth Count. AJP Rep. 2020;10(1):E78\u201386. https:\/\/doi.org\/10.1055\/s-0040-1708491.","journal-title":"AJP Rep"},{"key":"9190_CR25","unstructured":"WHO HIV, Hepatitis, and STIs Pregnancy and Breastfeeding Therapeutics Working Group. Antiretrovirals in pregnancy research toolkit. Available from: https:\/\/www.who.int\/tools\/antiretrovirals-in-pregnancy-research-toolkit. Cited 24 Jun 2025."},{"issue":"S2","key":"9190_CR26","doi-asserted-by":"publisher","first-page":"25922","DOI":"10.1002\/jia2.25922\/full","volume":"2022","author":"F Renaud","year":"2022","unstructured":"Renaud F, Mofenson LM, Bakker C, Dolk H, Leroy V, Namiba A, et al. Surveillance of ARV safety in pregnancy and breastfeeding: towards a new framework. J Int AIDS Soc. 2022;2022(S2):25922. https:\/\/doi.org\/10.1002\/jia2.25922\/full.","journal-title":"J Int AIDS Soc"},{"issue":"3","key":"9190_CR27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40264-024-01494-6","volume":"48","author":"R Schaefer","year":"2025","unstructured":"Schaefer R, Donaldson L, Chigome A, Escudeiro dos Santos M, Lamprianou S, Ndembi N, et al. Antiretroviral Use for HIV Prevention During Pregnancy: The Need to Strengthen Regulatory and Surveillance Systems in Africa. Drug Saf. 2025;48(3):209\u201316. https:\/\/doi.org\/10.1007\/s40264-024-01494-6 . PubMed PMID: 39873899.","journal-title":"Drug Saf"},{"issue":"6","key":"9190_CR28","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s40264-020-00925-4","volume":"43","author":"V Jusot","year":"2020","unstructured":"Jusot V, Chimimba F, Dzabala N, Menang O, Cole J, Gardiner G, et al. Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi. Drug Saf. 2020;43(6):583\u201393. https:\/\/doi.org\/10.1007\/s40264-020-00925-4 . PubMed PMID: 32239447.","journal-title":"Drug Saf"},{"issue":"1","key":"9190_CR29","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1186\/s12889-024-20029-3","volume":"24","author":"F Saidi","year":"2024","unstructured":"Saidi F, Shah S, Squibb M, Chinula L, Nakanga C, Mvalo T, et al. Evaluating the impact of HIV pre-exposure prophylaxis on pregnancy, infant, and maternal health outcomes in Malawi: PrIMO study protocol. BMC Public Health. 2024;24(1):2604. https:\/\/doi.org\/10.1186\/s12889-024-20029-3 . PubMed PMID: 39334032.","journal-title":"BMC Public Health"},{"key":"9190_CR30","unstructured":"QED.ai. ScanForm. Available from: https:\/\/about.scanform.ai\/#more-info. Cited 4 Jul 2025."},{"key":"9190_CR31","unstructured":"Ministry of Health. Malawi Service Delivery Guidelines and Standard Operating Procedures for the Provision of HIV Pre-Exposure Prophylaxis using Oral or Long-acting Injectable Options. 2 nd Edition. 2024. Report."},{"issue":"15","key":"9190_CR32","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1097\/QAD.0000000000000394","volume":"28","author":"KC Liu","year":"2014","unstructured":"Liu KC, Farahani M, Mashamba T, Mawela M, Joseph J, Schaik N, Van, et al. Pregnancy outcomes and birth defects from an antiretroviral drug safety study of women in South Africa and Zambia. AIDS. 2014;28(15):2259\u201368. 10. 1097\/QAD.0000000000000394 PubMed PMID: 25115319.","journal-title":"AIDS"},{"key":"9190_CR33","doi-asserted-by":"publisher","unstructured":"Zash R, Jacobson DL, Diseko M, Mayondi G, Mmalane M, Essex M, et al. Comparative safety of antiretroviral treatment regimens in pregnancy. JAMA Pediatr. 2017;171(10). https:\/\/doi.org\/10.1001\/jamapediatrics.2017.2222 . PubMed PMID: 28783807.","DOI":"10.1001\/jamapediatrics.2017.2222"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-026-09190-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09190-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09190-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:41:54Z","timestamp":1782888114000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12884-026-09190-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9190"],"URL":"https:\/\/doi.org\/10.1186\/s12884-026-09190-2","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The PrEP Pregnancy Registry was approved as a sub-study under the Path to Scale study protocol by the Malawi National Health Sciences Research Committee (NHSRC), protocol #23\/10\/4205, and the Georgetown University Institutional Review Board (IRB), protocol #00007311. It is jointly implemented and evaluated alongside the PRI\n                      3\n                      SM-PrIMO study protocol, which also received NHSRC approval under protocol #23\/08\/4178 and UNC Chapel Hill IRB approval protocol #23-2220. Both studies are conducted in accordance with the ethical principles of the Declaration of Helsinki.Individual consent is not obtained, as the registry is designed to reflect routine programmatic data collection. However, verbal consent is sought for follow-up to document pregnancy outcomes. Additional written consent is obtained for the nested PRI3SM-PrIMO Study safety cohort. All data will be de-identified for analysis. The registry evaluates the safety of only the US. Food and Drug Administration (FDA) approved and WHO-recommended PrEP options; oral TDF\/FTC or TDF\/3TC and injectable CAB-LA among pregnant women in real-world service delivery settings.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"695"}}